ST

UREUM KREATININ LFG KD

CKD
54.0 2.20 32.40 Stage 3 3
26.0 1.11 70.57 Stage 2 2
120.0 7.80 6.48 Stage 5 5
32.5 0.90 75.23 Stage 2 2
23.0 1.38 45.08 Stage 3 3
52.6 2.06 15.12 Stage 4 4
23.5 0.96 44.68 Stage 3 3
55.2 3.00 41.73 Stage 3 3
59.0 1.15 37.98 Stage 3 3
31.0 1.50 42.12 Stage 3 3
25.6 1.10 63.63 Stage 2 2
56.0 0.6 68.00 Stage 2 2
88.3 1.91 33.91 Stage 3 3
16.2 1.12 61.66 Stage 2 2
20.8 0.52 144.23 Stage 1 1
22.5 1.20 60.60 Stage 2 2
52.7 1.33 65.37 Stage 2 2
28.8 1.02 65.35 Stage 2 2
37.0 1.12 62.50 Stage 2 2
28.3 1.10 64.39 Stage 2 2
52.8 2.60 23.23 Stage 4 4
29.1 1.15 47.87 Stage 3 3
23.0 1.52 48.15 Stage 3 3
70.0 1.11 67.44 Stage 2 2
16.4 0.84 63.58 Stage 2 2
16.6 1.26 36.72 Stage 3 3
58 1.80 44.86 Stage 3 3
53.8 1.53 45.11 Stage 3 3
26.8 0.52 119.00 Stage 1 1
38.0 1.20 76.73 Stage 2 2
40 2.20 93.82 Stage 1 1
28.5 0.51 119.00 Stage 1 1
23.8 1.20 98.52 Stage 1 1
20.5 0.67 77.52 Stage 2 2
8.4 1.31 68.80 Stage 2 2
22.6 1.08 92.91 Stage 1 1
25.5 1.02 71.07 Stage 2 2
43.9 1.02 62.92 Stage 2 2
 Descriptives
kreatinin

Std. Std. Minimu Maximu

N Mean Deviation Error m m
Derajat 12 1.1717 .50181 .14486 .51 2.20
1
Derajat 15 1.2267 .50668 .13082 .52 2.60
2
Derajat 11 2.1055 1.99529 .60160 .90 7.80
3
Total 38 1.4637 1.19201 .19337 .51 7.80

Descriptives
LFG

Std. Std. Minimu Maximu

N Mean Deviation Error m m
Derajat 12 80.855 24.6793 7.1243 44.9 119.0
1
Derajat 15 60.867 26.9443 6.9570 23.2 144.2
2
Derajat 11 43.492 20.6005 6.2113 9.9 75.2
3
Total 38 62.149 28.0733 4.5541 9.9 144.2

Descriptives
ureum

Std. Std. Minimu Maximu

N Mean Deviation Error m m
derajat 12 32.483 14.5114 4.1891 8.4 58.0
1
derajat 15 37.233 21.9157 5.6586 16.2 88.3
2

derajat 11 45.673 28.4512 8.5783 23.0 120.0

3
Total 38 38.176 22.1516 3.5935 8.4 120.0

stckd
Frequen Valid Cumulative
cy Percent Percent Percent
Valid stadium 6 15.8 15.8 15.8
1
stadium 17 44.7 44.7 60.5
2
stadium 12 31.6 31.6 92.1
3
stadium 2 5.3 5.3 97.4
4
stadium 1 2.6 2.6 100.0
5
Total 38 100.0 100.0

ht1
Frequen Valid Cumulative
cy Percent Percent Percent
Valid stadium 5 41.7 41.7 41.7
1
stadium 5 41.7 41.7 83.3
2
stadium 2 16.7 16.7 100.0
3
Total 12 100.0 100.0
 ht2
Frequen Valid Cumulative
cy Percent Percent Percent
Valid stadium 1 6.7 6.7 6.7
1
stadium 9 60.0 60.0 66.7
2
stadium 4 26.7 26.7 93.3
3
stadium 1 6.7 6.7 100.0
4
Total 15 100.0 100.0

ht3
Frequen Valid Cumulative
cy Percent Percent Percent
Valid stadium 3 27.3 27.3 27.3
2
stadium 6 54.5 54.5 81.8
3
stadium 1 9.1 9.1 90.9
4
stadium 1 9.1 9.1 100.0
5
Total 11 100.0 100.0

stadiumht
Frequen Valid Cumulative
cy Percent Percent Percent
Valid stadium 12 31.6 31.6 31.6
1
stadium 15 39.5 39.5 71.1
2
 stadium 11 28.9 28.9 100.0
3
Total 38 100.0 100.0

1. Maulidina F. Faktor-Faktor yang Berhubungan dengan Kejadian Hipertensi di Wilayah

Kerja Puskesmas Jati Luhur Bekasi. Arsip Kesehat Masyarakat. 2019;4(1):20-23
2. Nosari fitrah G. Karakteristik dan Perilaku Mencari Pengobatan Pada Penderita
Hipertensi (Health Seeking Behavior). 2020;02(01):15-18
3. Kementerian Kesehatan RI. Laporan Riskesdas 2018;53(9):181–222. Available from:
http://www.yankes.kemkes.go.id/assets/downloads/PMK No. 57 Tahun 2013 tentang
PTRM.pdf
4. Kemenkes RI. Laporan Provinsi Maluku Utara Riskesdas 2018.
5. Kadir A. Hubungan Patofisiologi Hipertensi dan Hipertensi Renal. Bagian Ilmu Faal
Fakultas Kedokteran Universitas Wijaya Kusuma. 2016;5:15–25.
6. Setiati, Siti; Alwi, Idrus; Sudoyono, Aru. W; K. Simadibrata, Marcellus; Setiyohadi,
Bambang; Syam Ari F. Ilmu Penyakit Dalam. Ilmu Penyakit Dalam. 2014. 4125–4129
7. PERNEFRI. 11th Report Of Indonesian Renal Registry 2018. Irr [Internet]. 2018;1–46.
https://www.indonesianrenalregistry.org/data/IRR 2018.pdf
8. Rizki A. Gambaran Fungsi Ginjal Pada Pasien Hipertensi Esensial Yang Dirawat Jalan Di
Bagian Penyakit Dalam Rsup Dr. M. Djamil Padang. Jurnal Kesehatan
Andalas.2016;1(1):5-7
9. Pertiwi YP. Karakteristik Pasien Hipertensi Di Poliklinik Penyakit Dalam Rumah Sakit
Umum Daerah Dr.H.Chasan Boesoirie Ternate. Kieraha Medical Jurnal. 2019;1(1):1-9
10. Nuraini B. Risk Factors of Hypertension. Jurnal Fakultas Kedokteran Universitas
Lampung. 2015;4(5):10–9.
11. Noerhadi M. Hipertensi Dan Pengaruhnya Terhadap Organ-Organ Tubuh. Jurnal Fakultas
Ilmu Keolahra. 2008;4 (2):1–18.
12. Infodatin. Hipertensi.Jakarta : Pusat data dan informasi kementrian kesehatan RI.2014.
https://pusdatin.kemenkes.go.id
13. Yulanda G, dkk. Penatalaksanaan Hipertensi Primer. Jurnal Fakultas Kedokteran
 Universitas Lampung.2017;6:25–33.
14. Kemenkes RI. Pedoman Teknis Penemuan dan Tatalaksana Hipertensi. Jakarta :
Direktorat Pengendalian Penyakit Tidak Menular Direktorat Jenderal PP Dan PI
Departemen Kesehatan RI 2013.
15. Sudung O, Sari Y. Hipertensi Pada Remaja. Majalah Kedokteran Fakultas Kedokteran
UKI. 2018;32(1):30–40. Available from:
http://ejournal.uki.ac.id/index.php/mk/article/view/681
16. World Health Organization (WHO)/International Society of Hypertension (ISH) statement
on management of hypertension. Vol. 21, Journal of Hypertension. 2003. p. 1983–92.
17. Erdine S, Ari O. ESH-ESC guidelines for the management of hypertension. Herz.
2006;31(4):331–8.
18. Muhadi. JNC 8 : Evidence-based Guideline Penanganan Pasien Hipertensi Dewasa.
Cermin Dunia Kedokt. 2016;43(1):54–9.
19. &NA; Manual of Medicine. Vol. 127, The American Journal of the Medical Sciences.
1904. 720–721 p.
20. Krisnanda MY. Universitas Udayana. Laporan Penelitian Hipertensi.
2017:18.https://simdos.unud.ac.id/uploads/file_penelitian_1
21. Fitri RD. Diagnose Enforcement And Treatment Of High Blood Pressure. Jurnal
Kedokteran Universitas Lampung. 2015;4(3):47–51.
22. Verdiansah. Pemeriksaan Fungsi Ginjal. CDK Jurnal. 2016;43(2) p.148–54.
23. Hall JE. Guyton and Hall Textbook of Medicine Physiology.8th ed. Canada : Nelson
Education
24. Solandt DY. Introduction to Human Physiology. In: American Journal of Public Health
and the Nations Health. 1948. p. 1590–1590.
25. Rahmawati F. Laboratory Aspect Of Chronic Kidney Disease. Jurnal Ilmiah Kedokteran
Wijaya Kusuma. 2018;6(1):14–22.
26. Yaswir R, Maiyesi A. Pemeriksaan Laboratorium Cystatin C Untuk Uji Fungsi Ginjal. J
Kesehat Andalas. 2012;1(1):10–5.
27. A.Astrud, E.Arthur. Gambaran kadar kreatinin serum pada pasien penyakit ginjal kronik
stadium 5 non dialisis. Jurnal e-Biomedik. 2016;4(2):2–7.
28. Restu G. Karakteristik Penderita Hipertensi Yang Dirawat Inap Di Rumah Sakit Umum
Pusat Sanglah. Jurnal Fakultas Kedokteran Universitas Udayana. 2013;2(2):12–5.
29. Tirtasari S, Kodim N. Prevalensi dan Karakteristik Hipertensi Pada Usia Dewasa Muda di
Indonesia. Tarumanagara Medical Journal. 2013;1(2):395–402.
30. Sedayu B, Azmi S, Rahmatini R. Karakteristik Pasien Hipertensi di Bangsal Rawat Inap
SMF Penyakit Dalam RSUP DR. M. Djamil Padang Tahun 2013. J Kesehat Andalas.
2015;4(1):65–9.
31. Fitri T, Sihombing H, Artini IGA. Tingkat pengetahuan mengenai hipertensi. e-Jurnal
Med. 2017;6(12):164–9.
32. Sugiharto A, Hadisaputro S, Adi S, Chasani S. Faktor-Faktor Risiko Hipertensi Grade II
Pada Masyarakat ( Studi Kasus di Kabupaten Karanganyar ) Risk Factors of Grade II
Hypertension in Community ( Case Study at Karanganyar District ) PDF created with
pdfFactory Pro trial version www.pdffactory.com Fa. Ratio [Internet]. 2007;26. Available
from: http://eprints.undip.ac.id/5265/
33. Braunwald E, Zipes DP, Libby P. Braunwald: Heart Disease: A Textbook of
Cardiovascular Medicine, 6th ed., Copyright © 2001 W. B. Saunders Company.
Cardiovascular Diseases. 2001.
34. Anugraheni I, Puspitasari AW, Nidlom H. Hubungan Kadar Ureum Dan Kreatinin Serum
Dengan Tekanan Darah Pada Pasien Gagal Ginjal Kronik. Java Heal Jounal [Internet].
2014; Available from: http://jhj.fik-unik.ac.id/index.php/JHJ/article/view/17
35. Piani F, Cicero AFG, Borghi C. Uric acid and hypertension: Prognostic role and guide for
treatment. J Clin Med. 2021;10(3):1–15.
36. Medistra KF, Harihardjaja W, Mardana I. Hubungan Derajat dan Lamanya Hipertensi
dengan Kejadian Gagal Ginjal Kronik di Rumah Sakit Dustira. 2017;13.

Serum Creatinine Level In Hypertensive Patients: A Study From Uttarakhand, India